Tag Archives: Sprycel (dasatinib)

Sprycel (dasatinib) Drug Safety Communication

Share

translation servicesTranslate | French translation Spanish translation translate German translate Chinese Sprycel (dasatinib): Drug Safety Communication – Risk of Pulmonary Arterial Hypertension AUDIENCE: Hematology, Oncology ISSUE: FDA notified healthcare professionals that Sprycel (dasatinib) may increase the risk of a rare … Continue reading

Share
Posted in FDA 2011, FDA Notice, Hematology, Oncology | Tagged , , , , , , | Comments Off